Seminars in Oncology
Volume 31, Issue 6 , Pages 778-785 , December 2004

Induction chemotherapy in locally advanced squamous cell cancer of the head and neck: Evolution of the sequential treatment approach

  • Marshall R. Posner

      Affiliations

    • Departments of Medical Oncology, Surgical Oncology, and Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA
    • Corresponding Author InformationAddress reprint requests to Marshall R. Posner, MD, Medical Director, Head and Neck Oncology Program, Dana-Farber Cancer Institute, SW430, 44 Binney St, Boston, MA 02115
    • ,
  • Robert I. Haddad

      Affiliations

    • Departments of Medical Oncology, Surgical Oncology, and Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA
    • ,
  • Lori Wirth

      Affiliations

    • Departments of Medical Oncology, Surgical Oncology, and Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA
    • Department of Radiation Oncology, Beth Israel Deaconess Medical Center, Boston, MA
    • ,
  • Charles M. Norris

      Affiliations

    • Departments of Medical Oncology, Surgical Oncology, and Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA
    • ,
  • Laura A. Goguen

      Affiliations

    • Departments of Medical Oncology, Surgical Oncology, and Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA
    • ,
  • Anand Mahadevan

      Affiliations

    • Department of Radiation Oncology, Beth Israel Deaconess Medical Center, Boston, MA
    • ,
  • Christopher Sullivan

      Affiliations

    • Departments of Medical Oncology, Surgical Oncology, and Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA
    • ,
  • Roy B. Tishler

      Affiliations

    • Departments of Medical Oncology, Surgical Oncology, and Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA

References 

  1. Forastiere A , Koch W , Trotti A , et al.   Medical progress (Head and neck cancer) . N Engl J Med . 2001;345:1890–1900
  2. Fleming ID , Cooper JS , Henson DE , et al.   AJCC Cancer Staging Handbook. AJCC Cancer Staging Manual . Philadelphia, PA: Lippincott Williams & Wilkins; 1998;
  3. Lefebvre J , Chevalier D , Luboinski B , et al.   Larynx preservation in pyriform sinus cancer (Preliminary results of a European Organization for Research and Treatment of Cancer phase III trial) . J Natl Cancer Inst . 1996;88:890–898
  4. Forastiere AA , Goepfert H , Maor M , et al.   Concurrent chemotherapy and radiotherapy for organ preservation in advanced larynx cancer . N Engl J Med . 2003;349:2091–2098
  5. Veterans Affairs Laryngeal Cancer Study Group . Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer . N Engl J Med . 1991;324:1685–1689
  6. Calais G , Alfonsi M , Bardet E , et al.   Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced stage oropharynx carcinoma . J Natl Cancer Inst . 1999;91:2081–2086
  7. Depondt J , Gehanno P , Martin M , et al.   Neoadjuvant chemotherapy with carboplatin/5-fluorouracil in head and neck cancer . Oncology . 1993;50:23–27
  8. Domenge C , Hill C , Lefebvre J , et al.   Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma . Br J Cancer . 2000;83:1594–1598
  9. Pignon J , Bourhis J , Domenge C , et al.   Chemotherapy added to locoregional treatment for head and neck squamous-cell cancer (Three meta-analysis of updated individual data) . Lancet . 2000;355:949–955
  10. Paccagnella A , Orlando A , Marchiori C , et al.   Phase III trial of initial chemotherapy in stage III or IV head and neck cancers (A study by the Gruppo di Studio sui Tumori della Testa e del collo) . J Natl Cancer Inst . 1994;86:265–272
  11. Adelstein D , Li Y , Adams G , et al.   An Intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer . J Clin Oncol . 2003;21:92–98
  12. Posner M , Colevas A , Tishler R . The role of induction chemotherapy in the curative treatment of squamous cell cancer of the head and neck . Semin Oncol . 2000;27(suppl G):13–24
  13. Haddad R , Wirth L , Posner M . The integration of chemotherapy in the curative treatment of locally advanced head and neck cancer . Exp Rev Anticancer Ther . 2003;3:339–355
  14. Jacobs C , Goffinet D , Goffinet L , et al.   Chemotherapy as a substitute for surgery in the treatment advanced resectable head and neck cancer. A report from the Northern California Oncology Group . Cancer . 1987;60:1178–1183
  15. Ensley J , Jacobs J , Weaver A , et al.   Correlation between response to cisplatinum-combination chemotherapy and subsequent radiotherapy in previously untreated patients with advanced squamous cell cancers of the head and neck . Cancer . 1984;54:811–814
  16. Adelstein DJ . Induction chemotherapy in head and neck cancer . Hematol Oncol Clin North Am . 1999;13:689–698
  17. Harari P . Why has induction chemotherapy for advanced head and neck cancer become a United States community standard of practice? . J Clin Oncol . 1997;15:2050–2055
  18. Rooney M , Kish J , Jacobs J , et al.   Improved complete response rate and survival in advanced head and neck cancer . Cancer . 1985;55:1123–1128
  19. Munro A . An overview of randomized controlled trials of adjuvant chemotherapy in head and neck cancer . Br J Cancer . 1995;71:83–91
  20. El-Sayed S , Nelson N . Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region (A meta-analysis of prospective and randomized trials) . J Clin Oncol . 1996;14:838–847
  21. Richard J , Sancho-Garnier H , Pessey J , et al.   Randomized trial of induction chemotherapy in larynx cancer . Oral Oncol . 1998;34:224–228
  22. Staar S , Rudat V , Stuetzer H , et al.   Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy—Results of a multicentric randomized German trial in advanced head and neck cancer . Int J Radiat Oncol Biol Phys . 2001;50:1161–1171
  23. Monnerat C , Faivre S , Temam S , et al.   End points for new agents in induction chemotherapy for locally advanced head and neck cancers . Ann Oncol . 2002;13:995–1006
  24. De Andres L , Brunet J , Lopez-Pousa A , et al.   Randomized trial of neoadjuvant cisplatin and flourouracil versus carboplatin and fluorouracil in patients with stage IV-M0 head and neck cancer . J Clin Oncol . 1995;13:1493–1500
  25. Forastiere A , Metch B , Schuller D , et al.   Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous cell carcinoma of the head and neck (A Southwest Oncology Group study) . J Clin Oncol . 1992;10:1245–1251
  26. Jacobs C , Lyman G , Velez-Garcia E , et al.   A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck . J Clin Oncol . 1992;10:257–263
  27. Al-Kourainy K , Kish J , Ensley J , et al.   Achievement of superior survival for histologically negative versus histologically positive clinically complete responders to cisplatin combination in patients with locally advanced head and neck cancer . Cancer . 1987;59:233–238
  28. Spaulding M , Fischer S , Wolf G . Tumor response, toxicity, and survival after neoadjuvant organ-preserving chemotherapy for advanced laryngeal carcinoma . J Clin Oncol . 1994;12:1592–1599
  29. Urba S , Wolf G , Bradford C , et al.   Improved survival and decreased late salvage surgery using chemo-selection of patients for organ preservation in advanced laryngeal cancer . Proc Am Soc Clin Oncol . 2003;22:497; (abstr)
  30. Clark J , Busse P , Norris C , et al.   Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for squamous cell carcinoma of the head and neck (Long-term results) . J Clin Oncol . 1997;15:3100–3110
  31. Schrijvers D , Johnson J , Jimenez U , et al.   Phase III trial of modulation of cisplatin/fluorouracil chemotherapy by interferon alfa-2b in patients with recurrent or metastatic head and neck cancer . J Clin Oncol . 1998;16:1054–1059
  32. Vokes EE , Weichselbaum RR , Mick R , et al.   Favorable long-term survival following induction chemotherapy with cisplatin, fluorouracil, and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancer . J Natl Cancer Inst . 1992;84:877–882
  33. Haddad R , Norris C , Sulivan C , et al.   Docetaxel, cisplatin and 5-fluorouracil based induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (The Dana-Farber Cancer Institute experience) . Cancer . 2003;97:412–418
  34. Clark JI , Hofmeister C , Choudhury A , et al.   Phase II evaluation of paclitaxel in combination with carboplatin in advanced head and neck carcinoma . Cancer . 2001;92:2334–2340
  35. Hitt R , Lopez-Pousa A , Rodriguez M , et al.   Phase III study comparing cisplatin (P) & 5-fluoruracil (F) versus P, F and paclitaxel (T) as induction therapy in locally advanced head & neck cancer (LAHNC) . Proc Am Soc Clin Oncol . 2003;22:496; (abstr)
  36. Posner M , Glisson B , Frenette G , et al.   A multi-center phase I-II trial of docetaxel, cisplatinum, and 5-fluorouracil induction chemotherapy for patients with locally advanced squamous cell cancer of the head and neck . J Clin Oncol . 2001;19:1096–1104
  37. Shin DM , Glisson BS , Khuri FR , et al.   Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck . Cancer . 2002;95:322–330
  38. Murphy B , Li Y , Cella D , et al.   Phase III study comparing cisplatin (C) & 5-flurouracil (F) versus cisplatin & paclitaxel (T) in metastatic/recurrent head & neck cancer (MHNC) . Proc Am Soc Clin Oncol . 2001;20:224a; (abstr)
  39. Machtay M , Rosenthal DI , Hershock D , et al.   Organ preservation therapy using induction plus concurrent chemoradiation for advanced resectable oropharyngeal carcinoma (A University of Pennsylvania phase II trial) . J Clin Oncol . 2002;20:3964–3971
  40. Schrijvers D , Van Herpen C , Kerger J , et al.   Phase I-II study with docetaxel, cisplatin, and 5-fluorouracil in patients with locally advanced squamous carcinoma of the head and neck . Proc Am Soc Clin Oncol . 1999;18:A1524; (abstr)
  41. Janinis J , Papadakou M , Panagos G , et al.   Sequential chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil in patients with locally advanced head and neck cancer . Am J Clin Oncol . 2001;24:227–231
  42. Harrison LB , Pfister DG , Fass DE , et al.   Concomitant chemotherapy-radiation therapy followed by hyperfractionated radiation therapy for advanced unresectable head and neck cancer . Int J Radiat Oncol Biol Phys . 1991;21:703–708
  43. Taylor St , Murthy A , Caldarelli D , et al.   Combined simultaneous cisplatin/fluorouracil chemotherapy and split course radiation in head and neck cancer . J Clin Oncol . 1989;7:846–856
  44. Gandia D , Wibault P , Guillot T , et al.   Simultaneous chemoradiotherapy as salvage treatment in locoregional recurrences of squamous head and neck cancer . Head Neck . 1993;15:8–15
  45. Jeremic B , Shibamoto Y , Stanisavljevic B , et al.   Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck (A prospective randomized trial) . Radiother Oncol . 1997;43:29–37
  46. Vokes E , Stupp R , Haraf D , et al.   Hydoxyurea with continuous infusion paclitaxel, 5-fluorouracil and concomitant radiotherapy for poor-prognosis head and neck cancer . Semin Oncol . 1995;22:47–52
  47. Vokes EE , Stenson K , Rosen FR , et al.   Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy (Curative and organ-preserving therapy for advanced head and neck cancer) . J Clin Oncol . 2003;21:320–326
  48. Vokes E , Kies M , Haraf D , et al.   Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer . J Clin Oncol . 2000;18:1652–1661
  49. Kies MS , Haraf DJ , Athanasiadis I , et al.   Induction chemotherapy followed by concurrent chemoradiation for advanced head and neck cancer (Improved disease control and survival) . J Clin Oncol . 1998;16:2715–2721
  50. Haddad R , Tishler RB , Norris CM , et al.   TPF-based induction chemotherapy for head and neck cancer and the case for sequential, combined modality treatment . Oncologist . 2003;8:35–44
  51. Takimoto C , Rowinsky E . Dose-intense paclitaxel (Deja vu all over again?) . J Clin Oncol . 2003;21:2810–2814
  52. Cmelak A , Murphy BA , Burkey B , et al.   Induction chemotherapy (IC) followed by concurrent chemoradiation (CCR) for organ preservation (OP) in locally advanced squamous head and neck cancer (SHNC) (Results of a phase II trial) . Proc Am Soc Clin Oncol . 2003;22:501; (abstr 2016)
  53. Tishler R , Norris C , Colevas A , et al.   A phase I/II trial of concurrent docetaxel and radiation after induction chemotherapy in patients with poor prognosis squamous cell carcinoma of the head and neck . Cancer . 2002;95:1472–1481
  54. Colevas A , Busse P , Norris C , et al.   Induction chemotherapy with docetaxel, cisplatin, 5-fluorouracil, and leucovorin (TPFL5) for squamous cell carcinoma of the head and neck (A phase I/II trial) . J Clin Oncol . 1998;16:1331–1339
  55. Colevas A , Norris C , Tishler R , et al.   A phase II trial of TPFL (docetaxel, cisplatin, 5-fluorouracil, leucovorin) as induction for squamous cell carcinoma of the head and neck (SCCHN) . J Clin Oncol . 1999;17:3503–3511
  56. Colevas AD , Norris CM , Tishler RB , et al.   Phase I/II trial of outpatient docetaxel, cisplatin, 5-fluorouracil, leucovorin (opTPFL) as induction for squamous cell carcinoma of the head and neck (SCCHN) . Am J Clin Oncol . 2002;25:153–159
  57. Gray J , Meluch A , Greco F , et al.   Induction paclitaxel/carboplatin/5FU followed by concurrent radiotherapy and weekly paclitaxel/carboplatin for patients with locally advanced head and neck cancer (HNC) (A Minnie Pearl Cancer Research Network) . Trial Proc Am Soc Clin Oncol . 2001;20:226a; (abstr)

PII: S0093-7754(04)00404-X

doi: 10.1053/j.seminoncol.2004.09.007

Seminars in Oncology
Volume 31, Issue 6 , Pages 778-785 , December 2004

Article Tools

* Image Usage & Resolution